Methyl 2-(1,3-dioxo-1,2,3,4-tetrahydropyrrolo[1,2-a]pyrazin-4-yl)acetate, 97%, 500mg

Ethyl 5-(trifluoromethyl)imidazo[1,2-a]pyridine-2-carboxylate, 95.0%, 250mg

3,5-Diiodo-4-methoxypyridine, 95.0%, 250mg

3,6-Dihydro-2H-pyran-4-boronic acid pinacol ester, 98.0%, 100g

2-(1h-Inden-3-yl)ethan-1-amine hydrochloride, 95%, 100mg

Ethyl 4-fluorobenzo[b]thiophene-2-carboxylate, 95.0%, 1g

2-amino-1-(4-ethylphenyl)ethanol, 95.0%, 500mg

Cyclooctene>95.0%(GC)500mL

3-(Trifluoromethyl)phenyltrimethylammonium Hydroxide (5% in Methanol) [for Transesterification of Glyceride]25mL

1-(2,4-Dimethyl-1,3-thiazol-5-yl)methanamine, 95.0%, 1g

2-bromo-5-methyl-4-nitrophenol, 95%, 5g

1-Hexanol, min. 98 %, zur Synthese, 2.5 l, Glasverpackung

Thiazolidin-2-one>98.0%(GC)5g